Search

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Intratympanic steroids in Ménière's disease: what’s the evidence?

The days of drastic surgery for Ménière's disease are long gone. We know that intratympanic injections can deliver high doses of medication to the inner ear with minimal discomfort and minimal risk. But how do we choose from the myriad...

AI reshaping the landscape of head and neck cancer

With artificial intelligence set to transform almost every aspect of life, Abishek Mahajan reviews its potential to improve head and neck cancer care. Artificial intelligence (AI) has emerged as a transformative tool in healthcare. In the realm of oncology, AI...

Lyric 24/7 hearing: could it help those with tinnitus?

About Lyric Hearing Since its launch in 2008, Lyric represents the first and only device of its kind establishing a new category of hearing solution: 24/7 extended wear. Lyric is placed several millimetres within the ear canal, near the tympanic...

Tackling information overload and retention – interactive multimedia videos for first-time hearing aid users

If you are an audiologist reading this article, how confident are you that all the information and advice that you offer your first-time hearing aid (HA) patients is understood, absorbed and then acted upon once they leave the comfort of...

Hearing in middle-age: hearing impairment, tinnitus and hearing aid use in UK adults

Hearing loss has a well-documented adverse impact on emotional, social and physical well-being. In this article, Dr Piers Dawes from the University of Manchester gives an insight into his team’s recent work analysing the very large UK Biobank data set,...

Combined use of a hearing aid and a cochlear implant: a case study

When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...

Public health planning for hearing impairment (2017)

In 2009 Professor Andrew Smith and Dr Daksha Patel identified the need for awareness of public health methods in hearing healthcare planning. In 2010 the first training course was held, and since then 760 health workers from 41 countries have...

Cochlear implantation in children with single-sided deafness: rationale and early findings

Cochlear Implantation (CI) in children with single-sided deafness (SSD) is a controversial treatment option. Profs Karen Gordon, Papsin and Cushing discuss the rationale and early findings on the relative success of achieving binaural hearing for SSD with CI. If you’d...

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...

Cartilage conduction hearing aids: the third pathway for sound transmission and its application

Air-conduction and bone-conduction are familiar terms; now enter ‘cartilage conduction’. This new term offers a novel approach sound transmission. Hiroshi Hosoi explains the concept and proposes some future applications. The new sound pathway ‘cartilage conduction’ can provide various types of...

OTC hearing aids: where are we now?

The ‘Over-the-Counter Hearing Aid Act’ of 2017 set in motion plans for a long-debated shift in the hearing care market. In 2021, the FDA released draft guidance which will allow hearing aids in the US to be sold direct to...